PRIMARY AEROBIC BASE
Zone 2 Aerobic Conditioning
Sustained aerobic volume below the first ventilatory threshold (VT1) inducing eccentric left-ventricular hypertrophy and expanded stroke volume.
Effect Range
-8 to -15 bpm
Evidence Quality
Meta-Analysis (Grade A)
Time to Effect
6-12 Weeks
Confidence
High (Direct RCTs)
AUTONOMIC RECOVERY
Sleep Regularity & Dipping
Nocturnal parasympathetic dominance characterized by a 10% to 20% drop in heart rate relative to daytime resting baseline.
Effect Range
10% to 20% Dip
Evidence Quality
Cohort Study (Grade B)
Time to Effect
1-3 Weeks
Confidence
Moderate-High
AUTONOMIC TONE
Alcohol Reduction
Removal of nocturnal sympathetic activation, acetaldehyde toxicity, and suppressed HRV caused by evening ethanol metabolism.
Effect Range
-3 to -8 bpm Nocturnal
Evidence Quality
Cohort Study (Grade A)
Time to Effect
24-72 Hours
Confidence
High
RESPIRATORY SINUS ARRHYTHMIA
Resonance Frequency Breathing
Slow paced breathing at ~0.1 Hz (5.5 to 6 breaths per minute) maximizing baroreflex sensitivity and acute vagal tone.
Effect Range
-3 to -6 bpm Acute
Evidence Quality
Meta-Analysis (Grade A)
Time to Effect
Acute to 4 Weeks
Confidence
High
VASCULAR ENDOTHELIUM
Thermal Sauna Conditioning
Heat shock protein upregulation, shear-stress induced endothelial nitric oxide production, and post-cooling parasympathetic rebound.
Effect Range
-2 to -5 bpm Chronic
Evidence Quality
Prospective Cohort (Grade A)
Time to Effect
4-8 Weeks
Confidence
Moderate-High
METABOLIC LOAD
Adiposity & Load Reduction
Reduction of somatic vascular resistance, systemic low-grade inflammation, and non-stroke volume cardiac workload.
Effect Range
-0.6 to -1.0 bpm per kg
Evidence Quality
Meta-Analysis (Grade A)
Time to Effect
8-16 Weeks
Confidence
High
ADENOSINE BLOCKADE
Caffeine Intake Timing
Structuring caffeine consumption outside the 6-hour pre-sleep window to prevent nocturnal sympathetic tone elevation.
Effect Range
-2 to -4 bpm Nocturnal
Evidence Quality
Controlled Trial (Grade B)
Time to Effect
24-48 Hours
Confidence
High
AUTONOMIC HORMESIS
Cold Water Immersion
Acute peripheral vasoconstriction followed by sustained norepinephrine release and secondary parasympathetic rebound.
Effect Range
Vagal Rebound (rMSSD ↑)
Evidence Quality
Crossover Trial (Grade B)
Time to Effect
Acute to 2 Weeks
Confidence
Moderate